Results Validate In Vivo Liver DNA Base Editing as a Once-and-Done Approach to Treat Coronary Heart Disease by Lowering of LDL Cholesterol and PCSK9 Protein Levels Company Selects VERVE-101 as Lead Program to Treat Heterozygous Familial Hypercholesterolemia CAMBRIDGE, Mass.–(BUSINESS WIRE)–Verve Therapeutics, a biotech company pioneering gene editing medicines to treat cardiovascular disease, […]
Other News
Impulse Dynamics Closes $60 Million Financing
Funding to Accelerate Clinical and Product Development Pipelines, Commercialization of Optimizer Smart System for Heart Failure MARLTON, N.J.–(BUSINESS WIRE)–Impulse Dynamics, a company dedicated to helping healthcare providers improve the lives of people with heart failure, today announced the completion of a $60 million supplemental Series D crossover financing with new […]
HD Medical at CES Introduces HealthyU ™, World’s First All-in-One Smart Remote Patient Monitor for Telehealth and Wellbeing
– HealthyU ™ monitors multiple clinical parameters, plus 7-lead ECG and stethoscope integrated into one device – – Allows the patient and provider to connect remotely through an integrated platform – SANTA CLARA, California – ( BUSINESS WIRE ) – At CES’21, HD Medical Inc. today introduces HealthyU ™, an intelligent remote patient monitoring device, in […]
Rapid Medical Announces Appointment of James Romero as President, Americas
Experienced Neurovascular Device Executive will Lead Commercialization in US, Canada and LATAM YOKNEAM, Israel & FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–Rapid Medical, a company focused on the development of the first class of responsive, adjustable neurovascular devices, announces James Romero as the company’s President, Americas. Mr. Romero will oversee the growth and […]
Biotricity Announces New Solution for Personal Heart Management with Bioheart
Bioheart comfortably and continuously monitors daily activities and provides advanced heart performance data in a user-friendly format LAS VEGAS, Jan. 11, 2021 (GLOBE NEWSWIRE) — CES – Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the upcoming release of Bioheart, a personal heart monitor. Designed for individuals diagnosed with or at risk for cardiovascular disease, Bioheart continuously […]
OMRON Healthcare Continues to Transform the Heart Health Marketplace with New Remote Patient Monitoring Service & Digital Health Tools at CES 2021
Global heart health leader introduces VitalSight™, its first remote patient monitoring service, and previews a new app that will increase the capabilities of every OMRON connected blood pressure monitor LAKE FOREST, Ill., Jan. 11, 2021 /PRNewswire/ — OMRON Healthcare, Inc., the global leader in remote blood pressure monitoring and personal heart health […]
The Foundry Announces Successful First-In-Human Procedure In Study Of Innovative Transcatheter Mitral Valve Repair Technology
Novel Technology Brings Potential to Help Millions of Patients with Mitral Valve Regurgitation MENLO PARK, Calif., Jan. 11, 2021 /PRNewswire/ — The Foundry today announced the successful completion of the first-in-human procedure with the Half Moon Medical transcatheter mitral repair technology (TMVr) at Oregon Health and Science University (OHSU) as part of […]
Penumbra Announces Preliminary Unaudited Revenue for the Fourth Quarter and Full Year 2020
ALAMEDA, Calif., Jan. 11, 2021 /PRNewswire/ — Penumbra, Inc. (the “Company”) (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced certain unaudited preliminary revenue results for the fourth quarter and full year 2020 ahead of its participation at the 39th Annual J.P. Morgan Healthcare Conference on January 11-14, 2021. Q4 Revenue Highlights […]
Marizyme Announces the Use of DuraGraft® as the Standard-of-Care in Patients Undergoing Coronary Artery Bypass Surgery (CABG) at Vienna Heart Center North Floridsdorf
DuraGraft is a one-time intraoperative treatment used during vascular surgery to reduce the incidence of complications associated with graft failure JUPITER, Fla., Jan. 11, 2021 /PRNewswire/ — Marizyme, Inc. (OTCQB: MRZM), a global biotechnology company developing products to reduce the burden of ischemia-reperfusion injury in tissue grafting, organ transplant, and other surgical indications, today announced […]
CardioFocus® Announces Expanded Distribution Partnership With MicroPort™ CRM To Include Spain And Portugal
MARLBOROUGH, Mass., Jan. 11, 2021 /PRNewswire/ — CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), announced today that it has expanded its existing French distribution partnership agreement with MicroPort CRM in France to include both Spain and Portugal. “We are pleased to be represented by MicroPort CRM in France and have been very impressed by […]



